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When disability-adjusted life years are used to measure the burden of disease on a population in a time interval,
they can be calculated in several different ways: from an incidence, pure prevalence, or hybrid perspective. I show
that these calculation methods are not equivalent and discuss some of the formal difficulties each method faces.
I show that if we don’t discount the value of future health, there is a sense in which the choice of calculation
method is a mere question of accounting. Such questions can be important, but they don’t raise deep theoretical
concerns. If we do discount, however, choice of calculation method can change the relative burden attributed to
different conditions over time. I conclude by recommending that studies involving disability-adjusted life years be
explicit in noting what calculation method is being employed and in explaining why that calculation method has
been chosen.
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DiscountingBackground
When used to measure the burden of disease on a popu-
lation during a time interval, disability-adjusted life years
(DALYs) can be calculated in different ways – or, as it is
usually put, from different perspectives. Studies some-
times choose one method of calculation over the others
for reasons of convenience (based, say, on what type of
data they have access to) [1], and other times don’t even
acknowledge the issue, never explicitly saying what cal-
culation method is being used [2-7].a This is, I believe, a
serious mistake. Although the point isn’t frequently
recognized, the different ways of calculating DALYs yield
measurements of different quantities; they are not alter-
native approaches to quantifying the same thing [8]. It is
important that a calculation method be chosen with this
in mind.
In what follows, I’ll first explain the three main ways
in which DALYs can be calculated, from an incidence,
pure prevalence, or hybrid perspective, and I’ll show that
each method produces a measurement of a different
quantity. I’ll then discuss the formal features of each per-
spective and explain the apparent difficulties that eachCorrespondence: aschroeder@cmc.edu
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reproduction in any medium, provided the orfaces. I’ll show how this issue interacts with another im-
portant question in health measurement: whether the
value of future health states should be discounted. I’ll
show that if we don’t discount, there is a sense in which
the perspective issue is a “mere” question of accounting
which raises no deep conceptual concerns. On the other
hand, if we do discount, then the choice of perspective is
crucial. Different choices will result in changes to the
relative burden attributed to different diseases or risk
factors. I’ll conclude with a few recommendations.DALYs and time
All DALYs are calculated by adding YLLs (years of life
lost to premature mortality) to YLDs (years of life lived
with disability, multiplied by a disability weight [DW]
representing the severity of the condition).b This calcula-
tion is relatively simple when DALYs are not linked to a
time interval but instead are linked to a well-defined
population. If we want, for example, to know how many
DALYs were lost by the 1890 birth cohort, we can simply
count how many years prematurely the members of that
cohort died and then determine the duration of disability
they experienced, multiplied by severity. Many DALY
measurements, however, are linked to time. Instead of
looking at how many DALYs have been lost to lungd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and












Figure 1 Incidence DALYs. To calculate I-DALYs for year #2, look
for events – color changes – in year #2, and then add up the future
stream of ill health connected to those events. A sequela-based
measurement (see below) will count only Frank’s two years of
disability; a pathology-based measurement will also count his 2+
years of premature mortality, but will not count Carol’s four years of
premature mortality (unless her death was unrelated to her
disability).
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lost to lung cancer in 2004. This kind of measurement is
potentially very useful, since it allows us to track changes
over time, monitor the impact of policy interventions,
and the like. But it also raises a number of problems.c
Suppose, then, that we want to determine the number
of DALYs lost in 2004 to lung cancer. We know that all
DALYs are the sum of YLLs and YLDs. To determine
the number of YLLs due to lung cancer in 2004, it seems
reasonable to look at all the lung cancer deaths in 2004
and then to count how many years premature each
death was. So, if Sally dies from lung cancer in 2004 at
age 50, then (assuming a life expectancy of 80 years) that
means 30 years of life were lost.d To determine the
number of YLDs due to lung cancer in 2004, it seems
sensible to look at how many people suffered as a result
of lung cancer that year, and then to multiply those
person-years by the appropriate DW. So, if Jim experi-
ences mild (DW=0.2) disability throughout 2004 on ac-
count of his lung cancer, then 0.2 DALYs were lost on
account of his lung cancer in 2004.
This is, I think, the most intuitive way to think about
YLLs and YLDs in 2004, but note that the method – the
perspective – adopted for each component was quite dif-
ferent. We calculated YLLs by identifying a collection of
events (deaths) that took place in our time period and
determining the stream of future health losses associated
with those events. We calculated YLDs, on the other
hand, by looking at the states experienced in our time
period and adding that time up. Theoretically, it doesn’t
seem to make much sense to just add these results to-
gether to get the total DALYs lost to lung cancer in
2004, since they are based on very different methods
[8,9]. The resulting output wouldn’t measure anything
easily describable. It could best be summarized as the fu-
ture years of life lost to premature mortality due to
deaths in 2004 plus the amount of disability experienced
in 2004.
What, then, can we do to avoid that kind of chimeric
measure? The most common strategy is to change the
YLD calculation method to bring it in line with that
used to count YLLs. So, instead of looking at the amount
of disability experienced in 2004, we instead pick some
type of event and look at the future stream of disability
connected with events of that type occurring in 2004.
We might, for example, look at all disabling events, like
we looked at deaths. If I go permanently blind (DW=
0.6) in 2004 at age 30, we could attribute 50 years x
0.6 = 30 DALYs to 2004’s YLD count. Your blindness,
however, which struck in 2003, wouldn’t be counted at all;
its full impact would have been registered in 2003’s YLD
count. This approach is called an incidence perspective,
and it is the method most commonly used to calculate
DALYs. With a few qualifications to be discussed below,I-DALYs (incidence DALYs) for period T measure the
stream of lost health connected with events in T.
The second apparent solution to our original puzzle is
to take the opposite route and to change the method for
calculating YLLs to bring it in line with that used when
calculate YLDs [10]. Rather than looking at events that
happened in 2004, this would involve counting ill health
experienced in 2004. It’s very natural, as we saw, to do
this for disability, but it doesn’t make sense in the case
of death. No one “experiences” being dead. What we can
do, though, is add up the health that would have been
experienced in 2004, but for injury, disease, and so forth.
That is, we can calculate YLLs for 2004 by counting the
number of people who died in the past, whose natural
lifespan included 2004. So, the lung cancer death of a
50 year-old in 2000 would count as one YLL for each
year from 2001 through 2030, since the deceased would
have been alive in each of those years had she not
contracted lung cancer and instead lived out her natural
lifespan. This approach to calculating DALYs doesn’t
have a name, since (to my knowledge) it has never been
used. I’ll call it a pure prevalence perspective and call
DALYs calculated this way PP-DALYs. Roughly, PP-
DALYs for period T measure the amount of additional
health that would have been experienced in T, but for
injury, disease, and so forth.
Finally, the third response to our original puzzle has
been to ignore it – when calculate YLLs from an inci-
dence perspective and YLDs from a prevalence perspec-
tive and then to simply add the results.e This approach,
which is less common than the incidence approach, is
usually described in the literature as taking a prevalence
perspective, but for reasons which I hope are clear, I will
call it a hybrid perspective and call the resultant DALYs
H-DALYs. As mentioned earlier, H-DALYs don’t seem to
measure any nondisjunctively describable quantity.
Visually, all of this is represented in Figures 1, 2 and 3,
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Figure 2 Pure prevalence DALYs. To calculate PP-DALYs for year
#2, add up all the yellow (disability) and red (premature mortality)
that occur in year #2 on the chart.
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red represents time lost to premature mortality.
Conceptual choices and problems
Having briefly described the three main approaches to
calculating DALYs, I’ll now discuss each in more detail,
identifying some of the choices and problems each
perspective faces.
I-DALYs
DALYs are most commonly calculated from an incidence
perspective. This involves selecting some type of event,
identifying the events of that type that occur in the tar-
get time period, and then adding up the DALYs that are
connected to those events. Calculating I-DALYs there-
fore requires (1) choosing a type of event and then (2)
specifying how lost health is connected to events. (These
choices are rarely made explicit in the literature.) In
order not to undercount lost health, all lost health
should be connected to an appropriate event; but in
order not to overcount lost health, all lost health should
be connected to only one event. Here are four
possibilities:
1. Individuation by sequelae and death: “events” are the
onset of a sequela or a death; we connect all health
lost to a sequela or to death to its onset.f
2. Individuation by pathology: “events” are the onset of
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Figure 3 Hybrid DALYs. To calculate H-DALYs for year #2, add up
all the yellow (disability) that occurs in year #2, and then look for
any deaths in year #2, adding up the (future) years of life lost to
those deaths.3. Individuation by pathology and death: “events” are
the onset of a pathology or a death; we connect all
health lost to disability to the onset of its underlying
pathology, and we connect all health lost to death to
death.
4. Individuation by death: “events” are the death of an
individual; we connect all health lost by an individual
to her death.g
Suppose that Jane begins smoking in 1950. She con-
tracts chronic obstructive pulmonary disease in 1980,
which gives her six years of mild disability (DW=0.2),
followed by two years of serious disability (DW=0.5),
followed by death in 1988 at age 60. If we individuate by
sequelae and death and assume a life expectancy of
80 years, we’ll assign 6 × 0.2 = 1.2 DALYs to 1980; 2 ×
0.5 = 1 DALY to 1986; and 20 × 1= 20 DALYs to 1988. If
we individuate by pathology, we’ll assign all 22.2 DALYs
to 1980. If we individuate by pathology and death, we’ll
assign 2.2 DALYs to 1980 and 20 DALYs to 1988. If we
individuate by death, all 22.2 DALYs would be assigned
to 1988.
The first option is the method officially used in the
Global Burden of Diseases, Injuries, and Risk Factors
(GBD) Study [11]. Many studies claim to be using the
third option – while at the same time saying they are
following GBD methodology [12].h I mention the second
option because it seems more internally consistent than
the third and is used for calculating Healthy Life Years
(HeaLYs), a measure related to the DALY [13]. The
fourth method has never been used and probably never
will be. I mention it simply to show that there are many
possible ways of calculating I-DALYs. Some less obvious
ways may prove to be useful. In the above scenario, for
example, we might try to individuate by primary cause
or risk factor, assigning the 22.2 DALYs to Jane’s deci-
sion to smoke in 1950.
Given, then, the many different possible versions of an
incidence approach, it is important to be clear on the
method of calculating I-DALYs being used. It is also im-
portant to resist the temptation to describe I-DALYs as
measuring the amount of ill health lost due to causes of
a particular type in a time period. This may be true for
some methods of event individuation, but it is certainly
not true for all of them. (Individuation by pathology
comes the closest.) It is therefore more accurate to de-
scribe I-DALYs as measuring the amount of lost health
connected with events in a given time period and then to
explicitly define the connection relation.
Finally, note that in no intuitive sense are I-DALYs (of
whatever type) a measure of the health of a population
at a time or of the burden of disease on a population at
a time. Suppose, for example, that last year we were
struck by a massive epidemic that caused permanent
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population. If there are no new health problems (inci-
dent pathologies, sequelae, or deaths) this year, then zero
I-DALYs would be attributed to this year. But if someone
asked how healthy we were this year or whether we
experienced any burden resulting from disease, we
would surely answer that we were not at all healthy and
experienced a huge burden, since we’re blind, paralyzed,
and in chronic pain. Call this the polio problem, since
for many years in many countries polio would have
registered zero I-DALYs, despite having left many people
with serious disabilities.
PP-DALYs
Pure prevalence DALYs calculate YLDs by looking at the
gap between health actually experienced in some time
period and full health, and they calculate YLLs by count-
ing the number of people who died in the past but who
would have been alive in the time period had they lived
a normal lifespan. PP-DALYs are in a sense simpler than
I-DALYs, in that they don’t require defining things like
“events” and the connection relation. It is tempting to
say that they measure the amount of additional health
that would have been experienced in the time period but
for pathology, but there are two reasons why that isn’t
quite right. First, YLLs are calculated based on a some-
what arbitrary choice of target life expectancy. If we
truly had no ill health, people would live much longer
than 80 years. (In fact, if a fatal condition is considered
ill health, then absent ill health no one would ever die.)
Second, PP-DALYs are not designed to make this kind
of counterfactual assessment. If I become infertile, that
infertility will register a (small) number of DALYs each
year I experience it. But the health that would have been
experienced by the children I would have had, had I
been fertile, will not register on a PP-DALY measure.
So, it is more accurate to say that PP-DALYs measure
the amount of additional health that would have been
experienced in a given time period by past or present
members of some population, had they lived to an arbi-
trary age in good health. As with I-DALYs, this is not an
intuitive measure of the health of a population at a time.
Elvis Presley died in 1977 at age 42. He, therefore, would
still count for one YLL this year. But, intuitively, it does
not seem that we as a population are in poorer health
now because Elvis died 35 years ago. Call this the Elvis
problem.
H-DALYs
Hybrid DALYs are calculated by adding I-YLLs to P-
YLDs. As such, H-DALYs avoid both the polio and Elvis
problems. (The polio problem arises due to the use of I-
YLDs and the Elvis problem due to the use of P-YLLs.)
They also largely sidestep the difficulty facing I-DALYsin choosing “events.” Since only YLLs are calculated
from an incidence perspective, it seems natural to select
death as the event in question and then to connect all
years of life lost to the moment of death. Finally, H-
DALYs are a true period measure: all the data needed to
calculate H-DALYs can be measured in the time period
in question. (I-DALYs require a projection of the future
duration of disability, and PP-DALYs require knowledge
of deaths that occurred prior to the time period in ques-
tion.) These are the virtues of H-DALYs, and they are
considerable. Unfortunately, there are also serious pro-
blems. As we’ve seen, H-DALYs don’t measure any intui-
tively describable quantity, and they therefore appear to
lack theoretical justification.
I believe, however, that H-DALYs may be justifiable as
our elusive measure – or, more accurately, index – of
population health at a time, a role we saw that neither
I- nor PP-DALYs could plausibly fill. Some educational
assessment indices for schools include both a compo-
nent connected to the academic performance of stu-
dents (e.g., standardized test scores) and a component
that reflects the drop-out rate [14].i The thought is that
a school has in some sense failed in its mission if its stu-
dents perform badly on (well-designed) tests or if they
drop out. A school’s job is both to increase test scores
and to keep students in the system. Similarly, we might
think that we, as a population, are doing poorly with re-
spect to health if our members are living with disabil-
ities or if we are allowing our members to “drop out” of
the population by dying. The job of our health system is
both to decrease disability and to keep people alive. The
former component, I suggest, may plausibly be repre-
sented with P-YLDs, and the latter with I-YLLs. (I argue
for this claim more extensively in an unpublished manu-
script, “Measuring Health and the Problem of Changing
Populations.”)
DALYs, accounting, and discounting
Given, then, that we have (at least) three different ways
to calculate the DALYs lost for a given time period,
which one should we use? There is one sense in which
the decision might not seem like a theoretically signifi-
cant one. As we saw, these issues only arise when we try
to assign DALYs to time periods. If we ask, for example,
how many DALYs John lost to ill health, there is a sim-
ple answer. Similarly, if we ask how many DALYs mem-
bers of the Boston Red Sox lost to ill health, there is a
simple answer. Things only become complicated when
we ask how many DALYs members of the Boston Red
Sox lost to ill health in 2010. Our problem, then, is really
just one of accounting. We have a set number of DALYs
that have been lost, and we want to assign those DALYs
to different time periods. Each of the three methods
we’ve looked at provides an internally consistent way of
Schroeder Population Health Metrics 2012, 10:19 Page 5 of 7
http://www.pophealthmetrics.com/content/10/1/19doing that. There aren’t any deep metaphysical issues
raised when an accountant decides whether to calculate
asset depreciation annually versus allocating the entire
loss to the year of sale. Similarly, there is no principled
reason we can’t allocate DALYs to time periods in any
number of ways, so long as we do so consistently.
That said, there are two reasons why the choice of
accounting has at least practical importance. First, the
choice of perspective – the accounting method – may
make a difference in how certain diseases “look” over
time. After a successful vaccine has been developed,
certain illnesses will no longer show up in I-DALY mea-
surements but will continue to register in H- and PP-
DALY measurements. Certain cyclical diseases with last-
ing effects may appear only to be sporadic problems
from an incidence perspective while appearing to be
chronic problems from a pure prevalence or hybrid per-
spective. H- and PP-DALYs may appear to underesti-
mate the importance of a new, chronic health problem,
if most of its effects will occur in the future. Of course,
each of these problems can be corrected for by taking a
more comprehensive view. (We can correct for the last
problem, for example, by also looking at predicted fu-
ture H- and PP-DALYs.) But in the real world we know
that such care won’t always be taken, and so there is
potentially some practical importance in the choice of
perspective, because of the different “shape” or trajec-
tory it can give to different health problems.
Second, choice of perspective interacts with discount-
ing in a crucial way. The practical matters I mentioned
above concern the shape of different DALY measure-
ments. Calculated one way, a disease may show huge
periodic “spikes” of DALYs lost; calculated another, it
may register a relatively constant drain on the popula-
tion. But in the end, the total number of DALYs lost
over time will be the same, which is why the issues can
easily be corrected for by more carefully examining the
measurements and taking a broader view. If, however,
we discount the value of future health, this need not be
the case.
Suppose condition A affects 100 people per year and
gives each person exactly one year of serious disability
(DW=0.5). Condition B, which has two incident cases
each year, causes 50 years of equally serious disability. If
B’s incidence rate has been constant, it will eventually
have the same prevalence as A – 100 people will have
each condition at any given time. From a hybrid or pure
prevalence perspective, both A and B will register 100 ×Table 1 The impact of discounting and perspective choice on
Condition Incidence Duration Prevalence H- or PP-DALYs (w/or w/ou
A 100 1 100 50
B 2 50 100 500.5 = 50 DALYs per year, every year. This will be true
whether or not we discount the value of future health,
since both H- and PP-DALYs calculate YLDs by looking
at the health loss experienced this year.
When we calculate I-DALYs, however, things change.
Whether or not we discount, condition A will register
100 cases × 1 year × 0.5 = 50 DALYs each year. If we
don’t discount, condition B will register 2 cases ×
50 years × 0.5 = 50 DALYs each year. If we do discount,
however, we’ll get a much lower number for B, since the
heath loss in the future will count for less. (Using a low
3% discount rate, B will register 25.9 I-DALYs each year.)
This means that if we don’t discount, then H-, PP-, and
I-DALYs will all measure A and B as equally serious
health problems – 50 DALYs per year, every year. If we
do discount, H- and PP- DALYs will still count A and B
equally, but I-DALYs will register A as a much more ser-
ious health problem than B (50 vs. 25.9 DALYs). (See
Table 1). So, if we discount the value of future health,
then the choice of perspective becomes crucial – it can
have a huge effect on the relative burden assigned to dif-
ferent health problems, and this difference will not wash
out over time. The choice of perspective here no longer
seems like mere accounting.j
Conclusions
I’ve explained the many different ways to calculate
DALYs – from a pure prevalence, hybrid, or incidence
perspective (the last of which has several possible forms)
– and I’ve explained some of the conceptual choices and
problems that arise for each method. Returning to the
question that opened the last section: which is the right
one to use? Which perspective should we take when
measuring health? I think the answer, unsurprisingly, is
that since each measures a different quantity, each is
useful in different situations. If we are interested, for ex-
ample, in estimating the impact of lung cancer on this
year’s economic productivity, PP-DALYs are likely a use-
ful data point. H-DALYs may be a good choice when
evaluating the performance of a health care system, and
I-DALYs might be the best option if we’re deciding how
much money to allocate to different vaccine programs.
The important point to keep in mind is that PP-, H-,
and I-DALYs measure different things. That is, it is not
the case that we have a single quantity to measure,
population health in 2004 or the burden of disease in
2004, for which we have three candidate calculation
methods. Rather, we have three candidate quantities thatthe measured burden for two sample conditions
t discounting) I-DALYs (w/out discounting) I-DALYs (3% discount)
50 50
50 25.9
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health, the first question needs to be: what, exactly, do I
want to measure? A careful answer to this question will
much of the time suggest the proper calculation method.
Two further recommendations are in order. First,
those measuring health need to clearly describe their
calculation method. As has been noted, many studies do
not explain (much less justify) what calculation method
has been chosen, and those that do frequently relegate
the explanation to a footnote or appendix. For studies
adopting an incidence approach, it is very rare to find an
explicit mention of what “events” are being counted and
of how lost health is tied to those events. These choices
matter. It is important for them to be made clear so that
results can be properly interpreted and to ensure that
only properly comparable results are compared.
Second, I think it is important to speak more clearly
about DALYs and what they do and don’t measure. As
we noted above, neither I-DALYs nor PP-DALYs are
plausible candidates for measuring population health at
a time – recall the polio and Elvis problems – and so we
shouldn’t describe them as such. Rather, we should ex-
plicitly describe I-DALYs for time period T as measuring
the health loss connected with events (of whatever type)
occurring in T – or, somewhat more loosely, as measur-
ing the total health loss tied to new health problems in
T. And we should describe PP-DALYs for T as, loosely,
measuring the amount of additional health that would
have been experienced in T but for injury, disease, and
so forth. What about H-DALYs? I suggested that they
can be described as an index representing overall popu-
lation health for the period. This clarity of description
has a cost, of course. It is much easier, and more likely
to resonate with the public and with policymakers, to
simply describe DALYs as measuring population health
or the burden of disease for some period of time. But if
that simplicity comes at the price of misunderstanding, I
question whether it is worth it.
Endnotes
aThough none of these articles explicitly indicate
which calculation method is being used, in some (but
not all) cases it can be inferred from the paper.
bDisability weights raise a number of important issues
which I will set aside here. In particular, there is a ques-
tion about what a disability weight is supposed to repre-
sent – a quantity of health, the value of health states,
the well-being associated with health states, etc. The
resolution of this issue will affect much of what I say
below, about what each type of DALY seeks to measure,
in ways which should be straightforward.
cFor the remainder of the paper, whenever I speak of
DALYs, assume that I mean DALYs-for-time-period-T.
In particular, many of the recommendations I make atthe end of the paper do not necessarily apply to DALY
measurements that are not restricted to a time period.
dThe choice of life expectancy is another important,
difficult, and potentially problematic issue. But I will ig-
nore it here.
eThere is, logically, a fourth possibility: adding P-YLLs
to I-YLDs. I know of no one who has even mentioned
the possibility, though, and I can’t think of any context
in which it would be useful.
fThere is a sense in which we could simply call this
“individuation by sequelae,” where we consider death to
be a sequela. Since it is standard practice, however, to
reserve “sequela” for nonfatal conditions, I have chosen
the slightly longer formulation here.
gIn each of these cases, further work needs to be done
properly operationalize it. What distinguishes one se-
quela from another? (Is moderate back pain a different
sequela than severe back pain?) What counts as the
onset of a pathology? (Is it the initially asymptomatic
cancerous mutation or the appearance of symptoms?)
What counts as health lost to a pathology? (If I acciden-
tally drink from your glass because I’m blind and as a re-
sult catch a cold, should the resultant health loss be
attributed to my blindness?) These are important ques-
tions, but I’ll set them aside.
hEven the GBD Study itself makes this mistake. The
2004 update describes YLD as “years lost due to disabil-
ity. . .for incident cases of the disease or injury” [12].
Theo Vos (personal communication) has explained to
me that in the GBD Study, as well as in some national
burden of disease studies, an inconsistent mix of indi-
viduation by sequelae and death and individuation by
pathology and death has been used. For example, in past
GBD studies foot amputation from diabetes was treated
as a separate sequela, with YLD assigned to the time of
amputation. But YLD owing to different sequelae arising
from cancer were assigned to the original onset of
cancer.
iCalifornia’s Academic Performance Index (API) ori-
ginally included only components relating to student
achievement, creating perverse incentives for schools to
encourage poor performers to drop out or transfer. Re-
cent legislation has mandated that the API to be revised
to include a component reflecting a school’s retention
rate [14].
jDan Brock (personal communication) has raised the
question of whether these observations are relevant to
the much-debated issue of whether or not we should
discount the value of future health. There certainly is a
sense in which the perspective issue would be simpler if
we did not discount. Then, the choice of perspective
would really be one of accounting – it wouldn’t affect
the relative burden over time attributed to different con-
ditions. So, dispensing with discounting would be a way
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that might be thought to count in favor of doing so. I
suspect, however, that this consideration by itself
wouldn’t sway many advocates of discounting, since it is
already well known that discounting will shift the rela-
tive burden attributed to different conditions. (The cost
effectiveness of vaccination programs and programs to
alleviate the effects of climate change, for example, are
notoriously sensitive to the choice of discount rate.) I
think the relevance of the perspective issue to the ques-
tion of discounting, though, is worthy of further
investigation.
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